Back to BCRX
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC → BCRX
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$209K
Q3 2026
Peak value
$681K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $152K |
| Q4 2025 | $121K |
| Q1 2026 | $111K |
| Q2 2026 | $681K |
| Q3 2026 | $209K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $209K | 25.2K | — | — |
| Q2 2026 | $681K | 65.1K | — | — |
| Q1 2026 | $111K | 12.3K | — | — |
| Q4 2025 | $121K | 16.0K | — | — |
| Q3 2025 | $152K | 21.8K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M